Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma.
Arena A, Romeo MA, Focaccetti C, Anastasiadou E, Trivedi P, Cifaldi L, Gilardini Montani MS, Benedetti R, Santarelli R, Gonnella R, Benvenuto M, Marchese C, Masuelli L, Bei R, Cirone M.
Arena A, et al. Among authors: romeo ma.
Br J Haematol. 2023 Apr;201(2):e12-e15. doi: 10.1111/bjh.18688. Epub 2023 Feb 12.
Br J Haematol. 2023.
PMID: 36775956
No abstract available.